Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Catalent Further Expands Clinical Supply Network with New Facility in San Diego

Friday, October 29, 2021

Catalent a global leader in clinical supply servicestoday announced the opening a new facility in San Diego in response to increased demand from pharmaceutical and biopharmaceutical customers for integrated development clinical packagingand distribut...

Spero Therapeutics Submits New Drug Application to U.S. FDA for Tebipenem HBr for the Treatment of Complicated Urinary Tract Infections including Pyelonephritis

Thursday, October 28, 2021

Spero Therapeutics Inc a multiasset clinicalstage biopharmaceutical company focused on identifying developing and commercializing treatments in high unmet need areas involving multidrug resistant bacterial infections and rare diseases today announced...

XBiotech to Launch Novel Candidate Therapy for Stroke

Thursday, October 28, 2021

XBiotech announced its plan to commence a randomized placebocontrolled clinical study to test its new True Human antibody therapy for reducing brain injury after stroke The study will be conducted across the United States at leading medical centers t...

Siemens and Merck Collaborate to Boost Machine-to-Machine Trust in Industrial Value Chains

Thursday, October 28, 2021

Merck a leading science and technology company and Siemens an innovation leader in automation and digitalization Germany plan to develop and implement solutions that offer unprecedented levels of digital trust in MM connected industrial value chains...

Merck Launches Millicell® DCI Digital Cell Imager for Fast, Accurate, and Objective Cell Monitoring

Thursday, October 28, 2021

Merck has announced the launch of its new Millicell DCI Digital Cell Imager an instrument that helps improve cell culture lab productivity by assessing a broad range of parameters including confluency morphology and cell growth trends providing faste...

Recro Enters Into Master Commercial Supply and Services Agreement With Otsuka

Wednesday, October 27, 2021

Recro Pharma Inc a contract development and manufacturing organization CDMO dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development today announced the signing of a master supply and s...

Adagene Establishes Collaboration for Clinical Trial of ADG106 in Combination with Nivolumab in Patients with Non-Small Cell Lung Cancer in Singapore

Wednesday, October 27, 2021

Adagene Inc the National University Cancer Institute Singapore NCIS at the National University Hospital in Singapore National Cancer Centre Singapore NCCS and the Singapore Translational Cancer Consortium STCC today announced the initiation of a phas...

Silo Pharma Enters into Sponsored Research Agreement with Columbia University to Develop Psychedelic Therapeutics for Alzheimer's Disease

Wednesday, October 27, 2021

Silo Pharma Inc a developmentstage biopharmaceutical company focused on the use of psychedelics as a therapeutic today announced that it has entered into a sponsored research agreement with Columbia University pursuant to which Silo has been granted...

Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for Phase 1/1b Clinical Trial of ITK Inhibitor CPI-818 in China

Wednesday, October 27, 2021

Corvus Pharmaceuticals Inc a clinicalstage biopharmaceutical company today announced that the IND application submitted by its partner in China Angel Pharmaceuticals Ltd Angel Pharma has been approved by the Center for Drug Evaluation CDE of the Chin...

Takeda to Acquire GammaDelta Therapeutics to Accelerate Development of Allogeneic γδT Cell Therapies Addressing Solid Tumors

Wednesday, October 27, 2021

Takeda Pharmaceutical Company Limited announced the exercise of its option to acquire GammaDelta Therapeutics Limited GammaDelta a company focused on exploiting the unique properties of gamma delta T cells for immunotherapy Through the acquisition T...